Drugs / Provodine
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02600871 | Dec 2015 → Apr 2017 | skin infection | The University of Texas Health Science Center at San Antonio | Completed | No outcome recorded |
| Phase 4 | NCT04023682 | Dec 2013 → Nov 2014 | — | Sundara Reddy | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01818167 Comparator | Jan 2013 → Dec 2014 | hidradenitis suppurativa | Henry Ford Health System | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Provodine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02600871 ↗ |
| Route | Topical | “Provodine™ topical cream” NCT01818167 ↗ |